Loading...
Market
Outcome of PorMedTec's next GM pig kidney transplant in macaque by June 2025?
2
Resolution / Starting Odds
Successful with no complications • 25%
Successful with minor complications • 25%
Unsuccessful • 25%
Not conducted • 25%
Official reports or studies published by PorMedTec or collaborating universities
Story
Japanese Startup Achieves First Genetically Modified Pig Kidney Transplant in Macaque for Clinical Application
Nov 25, 2024, 06:37 AM
A Japanese startup, PorMedTec, has successfully transplanted a genetically modified pig kidney into a crab-eating macaque, marking the first such procedure in Japan. This domestic first experiment aims to address the shortage of transplant organs and move towards clinical trials in humans. The kidney was modified to prevent rejection, and the macaque was able to urinate post-transplantation. The success of this experiment, conducted in collaboration with a university, is seen as a step towards establishing xenotransplantation technology for kidney disease patients.
View original story
Similar markets
Yes • 50%
No • 50%
Rejection issues • 25%
Infection complications • 25%
Ethical concerns • 25%
Other challenges • 25%
Less than 1 month • 25%
1 to 6 months • 25%
6 to 12 months • 25%
More than 12 months • 25%
NYU Langone • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
0-1 • 25%
2-3 • 25%
4-5 • 25%
More than 5 • 25%
Less than 5 • 25%
5 to 10 • 25%
11 to 20 • 25%
More than 20 • 25%